ashish gujarathi
ashish gujarathi
1 hours ago
Share:

Strategic and Competitive Analysis of the Aortic Endografts Market, 2025-2034

The global aortic endografts market was valued at $3.3 billion in 2024, and is projected to reach $6.2 billion by 2034, growing at a CAGR of 6.3% from 2025 to 2034. 

Aortic endografts are also referred to as stent-grafts. These are modern medical devices that are used in endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR), which are performed to treat aneurysms in the aorta, which is the main artery for carrying blood from the heart to the rest of the body. Aortic endografts are known to provide a safe alternative to traditional open surgery. These help reduce risk of complication and the time of operation. These also lessen the duration of patient recovery and hospital stay.    

Increase in aging population and rise in detection of aortic aneurysms using imaging technologies fuel the demand for aortic endografts in the market. Developments in material science also foster the growth of the market. In addition, there is a rise in demand for minimally invasive procedures, which help reduce recovery time, lower surgical risk, and shorten overall hospital duration. This rise in preference toward minimally invasive procedures drives the demand for aortic endografts. Moreover, improvements in imaging, delivery systems and device design help enhance the success rate of the procedure. This also fosters the growth of the market. 

The global aortic endografts market was valued at $3.3 billion in 2024, and is projected to reach $6.2 billion by 2034, growing at a CAGR of 6.3% from 2025 to 2034. 

However, the high cost of the aortic endograft devices and the associated procedures limit the growth of the market. Nevertheless, developments in healthcare infrastructure, advancements in technology, such as imaging and 3D printing, and the surge in focus on research and development in aortic endografts are the factors projected to be opportunistic toward the market growth. 

Developments in Aortic Endografts 

Modern aortic endografts help diagnose complex anatomies and improve long-term outcomes. Introduction of new designs, such as branched and fenestrated stent-grafts, allow for blood flow to vital arteries near the aneurysm site. In addition, these devices can be tailored as per the requirements of the patients, which helps improve fitness as well as performance. Further, manufacturers are focusing on low-profile delivery systems to facilitate procedures in patients with smaller or heavily calcified arteries. These devices allow for easier navigation through the vascular system, reducing the need for surgical access and minimizing trauma. The integration of 3D imaging and intraoperative navigation systems has also improved the precision of endograft placement. This is projected to foster the growth of the market. 

Frequently asked questions 

  • What are the key growth strategies of the aortic endografts industry players? 
  • Which region is expected to provide more business opportunities for this industry in the coming years? 
  • Who are the leading industry players in this sector? 
  • What are the driving factors and opportunities in the global aortic endografts industry? 

Regional Insights 

North America leads the global aortic endografts market due to the presence of advanced healthcare infrastructure and surge in adoption of minimally invasive technologies.   The Asia-Pacific region is experiencing rapid growth, driven by increase in healthcare investment, rise in awareness of aneurysm treatment, and surge in aging population across the region. 

List of Key Players 

  • Medtronic plc 
  • Cook Group 
  • W. L. Gore & Associates, Inc. 
  • MicroPort Scientific Corporation 
  • Terumo Corporation 
  • Endologix Inc. 
  • Braile Biomédica S.A. 
  • Bentley InnoMed GmbH 
  • Artivion, Inc. 
  • Cordis Corporation 

Summing up 

The growth of the aortic endografts sector is driven by technological innovations, including advanced device designs, personalized grafts, and integrated imaging tools. These advancements not only enhance procedural safety and success but also expand treatment options for patients with previously unsuitable anatomies.  

Furthermore, the report offers growth drivers, opportunities, and restraints to better understand the market dynamics. It further highlights key investment areas and analyzes the competitive scenario of the industry & the role of each stakeholder with the help of Porter’s five forces. Value chain analysis for this industry, which includes R&D, components manufacturers, assembly, programming & testing, marketing & sales, customers, and post-sales services, is explained in the report. The report also features strategies adopted by key market players to maintain their foothold in the market.

Recommended Articles

Strategic and Competitive Analysis of the Aortic Endografts Market, 2025-2034 - Globhy